Delivery systems for vorinostat in cancer treatment: An updated review - ScienceDirect
Vorinostat (SAHA) | HDAC Inhibitor | MedChemExpress
Clinical trials of vorinostat in combination therapy in patients with... | Download Table
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker | British Journal of Cancer
Vorinostat in single agent trials | Download Table
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition | Cell Death & Disease
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia | Clinical Epigenetics | Full Text
Vorinostat - wikidoc
References in Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial - The Lancet Oncology
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells - Okubo - 2020 - Cancer Science - Wiley Online Library
IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML
Table 1 from Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. | Semantic Scholar
A trial of vorinostat for advanced mesothelioma | Cancer Research UK
Vorinostat - Wikipedia
Targeting histone deacetylases: development of vorinostat for the treatment of cancer | Epigenomics
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data -
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug | Nature Biotechnology
Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance | Cell Death & Disease
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat - Experimental Hematology
Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity - ScienceDirect
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies | Scientific Reports
Vorinostat in published phase II clinical trials in solid tumors. | Download Table
Vorinostat | C14H20N2O3 - PubChem
Frontiers | Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent | Cell and Developmental Biology
Adding Vorinostat to Revlimid Post-transplant Maintenance Therapy… – Myeloma Research News
